SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A run of successful SpaceX missions, including Starship reaching orbit and multiple launches in a short span, is fueling bullish attention. Traders are cheering the execution and possible momentum or short-covering, while skeptics point to valuation concerns, resistance, and the risk of a pullback.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nikes quarterly report and cautious fiscal 2027 outlookamid falling sales and sharp weakness in Chinaare driving the selloff and renewed doubts about its turnaround. Traders are split between expecting further declines and buying the pullback on hopes the bad news is priced in, with some anticipating a rebound or short squeeze.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is under pressure after reports that Toshiba plans to double hard-drive capacity for AI data centers, raising concerns about future competition and HDD pricing power. Many traders call the selloff an overreaction and are buying the dip, while others warn that added supply could eventually weaken margins.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Shareholder approval of Evernorths business combination with Armada, which is expected to establish a large XRP treasury, is driving XRPNs sharp rally. Traders are focused on a potentially tight float and the warrants perceived discount, while skeptics warn that the move may be speculative and vulnerable to profit-taking.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians record Q3 deliveries beat analyst expectations, but the company reaffirmed rather than raised its annual delivery outlook, prompting a sell-the-news reaction. Bulls point to R2 growth and improving volume, while bears say the beat was already expected and profitability remains unproven.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

A reported Toshiba plan to double hard-drive capacity for AI data centers has pressured Seagate and Western Digital on concerns that added supply could weaken pricing power. Traders are divided: many call the selloff an overreaction and are buying the dip, citing strong AI-storage demand and a slow capacity ramp, while others see a medium-term competitive risk.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwires Sophia Space orbital-computing partnership and Honda robotics work are fueling discussion, alongside its selection for a Space Force contract vehicle. Bulls see long-term growth opportunities, while skeptics argue that partnerships and contract eligibility need to translate into firm revenue as the stocks weak, volatile trading continues.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Positive 24-month HOPE-3 extension data for Capricors Duchenne treatment deramiocel has renewed attention, with bullish traders saying it strengthens the case for FDA approval. Others caution that open-label results may not resolve the FDAs prior statistical concerns, keeping the pending decision binary; short-squeeze talk is prominent but speculative.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MXLs sharp advance is being linked by traders mainly to a broader semiconductor rally after the jobs report, alongside continued interest in its AI data-center optics story. Some see momentum continuing, while others say there is no company-specific news and view the move as overbought or driven by FOMO.

NetApp, Inc. engages in the provision of software, systems, and services to manage and share data on-premises. The firm also offers private and public clouds worldwide. It operates through the Hybrid Cloud and Public Cloud segments. The Hybrid Cloud segment provides a data storage portfolio for storage management and infrastructure solutions. The Public Cloud segment refers to a portfolio of products delivered primarily as-a-service. The company was founded by David Hitz, James K. Lau, and Michael Malcolm in April 1992 and is headquartered in San Jose, CA.

Netapp Inc

NetApps strong quarterly results and raised outlook have drawn attention, but shares sold off as traders focused on weaker free cash flow and a projected gross-margin decline. Bulls argue the cash use reflects inventory built for growth in AI-related storage demand, while bears question whether margins and cash generation can hold up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

iBio, Inc. (NASDAQ:IBIO) Given Consensus Recommendation of "Buy" by Analysts

Shares of iBio, Inc. (NASDAQ:IBIO - Get Free Report) have been given an average recommendation of "Buy" by the six brokerages that are covering the firm, MarketBeat reports. One research analyst has...

iBio (IBIO) Projected to Post Quarterly Earnings on Friday

iBio (NASDAQ:IBIO) will be releasing its Q3 2026 earnings before the market opens on Friday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-1-ibio-inc-stock-3...

iBio (NASDAQ:IBIO) Earns Buy Rating from Chardan Capital

Chardan Capital restated a "buy" rating and issued a $5.00 target price on shares of iBio in a report on Thursday...

iBio Details Generative AI Antigen Platform to Speed GPCR Antibody Discovery and Close Trust Gap

iBio (NASDAQ:IBIO) is seeking to narrow what it views as a growing trust gap between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market...

IBIO Stock Is Soaring Today After iBio's Muscle-Preserving Drug Receives Approval For Human Trial In Australia

Equity

iBio stated that IBIO-600 has been approved by Australia’s Therapeutic Goods Administration to initiate a Phase 1 study in overweight and obese adult participants.

iBio, Inc. (NASDAQ:IBIO) Given Average Recommendation of "Buy" by Analysts

iBio, Inc. (NASDAQ:IBIO - Get Free Report) has received a consensus recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. One research...

iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded iBio from a "sell" rating to a "hold" rating in a report on Saturday...

Insider Buying: iBio (NASDAQ:IBIO) CFO Buys 24,835 Shares of Stock

iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of $2.02 per...

iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares

iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the company's stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of...

Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock

iBio, Inc. (NASDAQ:IBIO - Get Free Report) insider Martin Brenner purchased 12,336 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average cost of $2.02...

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

iBio Inc

Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Feed

News

Sentiment

Fundamentals

Info

IBIO iBio Inc

Fundamentals

Latest IBIO News